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KAJIAN IN VITRO ANTIOKSIDAN, ANTIANGIOGENIK DAN 
VASORELAKSAN EKSTRAK DAUN CLERODENDRON SERRATUM 
(SPRENG.) 
 
ABSTRAK 
Clerodendron serratum (Spreng.) daun dari keluarga Verbenaceae, dikenali sebagai 
“Timba Tasek” dalam bahasa Malaysia adalah sejenis tumbuhan ubatan teradisional 
Melayu yang digunakan untuk merawat berbagai jenis penyakit. Walau pun begitu, 
penyelidikan ini terfokus kepada mengevaluasi aktiviti antiangiogenik, vasorelaksan 
dan antioksidan serta kandungan kimia ektrak daun C. serratum. Serbuk daun kering 
C. serratum di maserasi secara bersiri dengan eter petroleum (langkah menyah 
lemak), kloroform, methanol dan air. Aktiviti antiangiogenik (kesan perencatan 
ekstrak ini keatas pertumbuhan/pembentukan salur darah) telah diselidiki 
menggunakan assai cincin aorta tikus. Aktiviti vasorelaksan telah diselidiki dengan 
memeriksa kesan perencatan ekstrak daun C. serratum keatas gerakbalas 
penguncupan dos kumulatif noradrenalin sediaan terasing cincin aorta tikus. Kesan 
antioksidan pula telah ditentukan menggunakan assai “DPPH* radical scavenging 
activity” dan “Trolox equivalent antioxidant capacity (TEAC)”. Didapati diantara 
ekstrak-ekstrak, ekstrak metanol (ME-CS) menunjukan  kesan antiangiogenik, 
vasorelaksan dan antioksidan yang  paling poten. Oleh itu, ME-CS telah difraksinasi 
menggunakan n-heksan, kloroform, etil asetat, n-butanol dan air. Diantara fraksi-
fraksi, didapati fraksi n-butanol dari ME-CS menunjukan kesan antiangiogenik, 
vasorelaksan dan antioksidan yang paling poten. Kajian fitokimia menunjukan fraksi 
n-butanol mengandungi sebatian polifenol yang relatif tinggi dan sedikit terpenoid 
dan saponin. Oleh kerana aktiviti paling poten untuk ketiga-tiga aktiviti (antioksidan, 
antiangiogenik dan vasorelaksan) terdapat dalam fraksi yang sama (fraksi n-butanol 
 xxiii 
dari ME-CS), besar kemungkinan yang kesemua aktiviti di hasilkan oleh kumpulan 
bahan kimia yang sama. Aktiviti antioksidan mungkin terlibat dalam menghasilkan 
aktiviti antiangiogenik dan vasorelaksan daun C. serratum. 
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IN VITRO ANTIOXIDANT, ANTIANGIOGENIC AND VASORELAXANT 
STUDIES OF CLERODENDRON SERRATUM (SPRENG.) LEAVES 
EXTRACTS 
 
ABSTRACT 
 
Clerodendron serratum (Spreng.) leaves from Verbenacea family, locally known as 
“Timba Tasek” is a traditional Malay medicinal plant used for treating various 
diseases. However, the present works were focused on evaluating its antiangiogenic, 
vasorelaxant and antioxidant activities as well as chemical profiles of the leaves 
extracts. The dried powdered leaves of C. serratum were serially macerated with 
petroleum ether (a defatting step), chloroform, methanol and water. The 
antiangiogenic activity (the inhibitory effects of these extracts on blood vessel 
growth/formation) was studied using rat aortic ring assay. The vasorelaxant activity 
was studied by examining the inhibitory effect of C. serratum extract on contractile 
responses of cumulative doses of noradrenaline in isolated rat aortic ring preparation. 
The antioxidant activity was determine using DPPH• radical scavenging activity and 
Trolox equivalent antioxidant capacity (TEAC) assays. It was found that amongst the 
extracts, the methanolic extract (ME-CS) showed the most potent antiangiogenic, 
vasorelaxant and antioxidant activities. Therefore, the methanolic extract was 
fractionated using n-hexane, chloroform, ethyl acetate, n-butanol and water. 
Amongst the fractions, the n-butanol fraction of ME-CS showed the most potent 
antiangiogenic, vasorelaxant and antioxidant activities. Phythochemical study 
revealed that n-butanol fraction contains relatively large amount of polyphenolics 
compounds and some terpenoids and saponins. Since, all three activities (antioxidant, 
antiangiogenic and vasorelaxant) end up in the same fraction, it is very likely that all 
 xxv 
the activities were contributed by the same group of chemical compounds. The 
antioxidant activity may be involved in its antiangiogenic and vasorelaxant activities 
of C. serratum leaves. 
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CHAPTER ONE 
GENERAL INTRODUCTION 
1.1. The Usage of Medicinal Plants 
Traditional medicines, particularly herbal medicines have been used for 
thousands of years in maintaining health as an alternative to or in conjunction with 
modern medicines. The World Health Organization (WHO) has defined herbs to 
include crude plant materials such as leaves, flowers, fruits, seeds, stems, wood, 
barks, roots, rhizomes or other parts of plant which may be entirely fragmented or 
powdered. On the other hand, herbal products consist of herbal preparations made 
from one or more than one herb. Herbal medicine is defined as the use of crude 
materials of plant origin to treat illness or to promote health. It may contain 
excipients in addition to the active ingredients. In their unprocessed state, these 
herbal drugs are usually in the dried form but are sometimes stored fresh. Certain 
exudates may also be considered as herbal drugs (WHO, 2007a). 
 
As we know, the use of plants in herbal therapy has been based on 
humankind’s attempt to free itself from diseases descending from empirical findings 
of hundreds and thousands of years to provide new therapy. The traditional cultures 
of herbal medicine may not understand the scientific rationale behind their 
medicines, but they developed through trial and error from personal experience or 
collective tradition and the memories of their parents and grandparents. All scientific 
disciplines now recognize the importance of herbal plants as sources of medicine and 
have initiated active research programmes either to isolate new compounds or to 
produce standardized extracts as a source of medicines. It is a fact that 25% of all 
medical prescriptions are based on substances derived from herbal drugs of plant 
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origin or plant-derived synthetic analogues (Gurib-Fakim, 2006; Vitalini et al., 
2009).  
 
However, during the later part of 20th century, as science advanced, drugs 
were synthesized and herbalism declined. Newly developed principles of organic 
chemistry made it possible to replicate plant-produced chemicals leading to the 
synthesis of new compounds that preserved the beneficial properties of the natural 
chemical, but minimized its toxic effects (Swarbrick, 2007). Many drugs available in 
the market today are from herbal origin. In the world, 80% of people depend on 
medicinal plants for medicine, lack of access to medicines prescribed by modern 
medicine but also because these plants often have a real impact (Zabri et al., 2009), 
among modern medicines. 
 
Today, natural products compounds discovered from medicinal plants (and 
their analogues thereof) have provided numerous clinically useful medicines (Jachak 
& Saklani, 2007). In 2001 and 2002, approximately one quarter of the best-selling 
drugs worldwide were natural products or derived from natural products (Balunas & 
Kinghorn, 2005). Herbal medicine is one of the most important areas in which 
compounds isolated from plants source have contributed successfully in 
cardiovascular research. Aspirin, atropine, ephedrine, digoxin, morphine, quinine, 
reserpine and tubocurarine are a few examples of plant-based drugs, which were 
originally discovered through the study of traditional medicine (Gilani & Atta ur, 
2005).  
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Herbal plants have a long history of use in the treatment of cancer. 
Accordingly, there is a considerable scientific and commercial interest in the 
continuing discovery of new anticancer agents from all natural product sources, 
including plant secondary metabolites (Gurib-Fakim, 2006). Now, it is well 
established that herbal plants have been a useful source for clinically used anticancer 
drugs (Gordon et al., 2007). A number of promising new agents are under clinical 
development based on selective activity of these drugs against cancer-related 
molecular targets. Examples of plant active constituents used as anticancer agents are 
vinblastine, vincristine, camptothecin derivatives, topotecan and irinotecan, 
etoposide (derived from epipodophyllotoxin), and paclitaxel (Taxol®) (derived from 
the bark of the Pacific Yew, Taxus brevifolia Nutt) (Cragg & Newman, 2005). The 
natural-derived products, paclitaxel and camptothecin were estimated to account for 
nearly one-third of the global market for anticancer or about three billion USD of 
nine billion USD in total annually in 2002 (Oberlies & Kroll, 2004).  
 
The use of plants, plant extracts, or plant-derived pure chemicals to treat 
disease is a therapeutic approach, which has stood the test of time. Indeed today 
many pharmacological classes of drugs include a natural product prototype. The 
search for new molecules could be undertaken within the plant and animal 
biodiversity using ethnopharmacology data. This approach allows us to select plants 
potentially active and increase significantly the number of discovery of new products 
assets (Zabri et al., 2009). A number of drugs of plant origin have recently been 
introduced to the market, including artemether, galantamine, nitisinone, and 
tiotropium, or are currently involved in late-phase clinical trials (Balunas & 
Kinghorn, 2005).  
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1.2. The Plant Literature Review: Clerodendron serratum (Spreng.)  
1.2.1. Botanical Description 
 
The C. serratum is a herbaceous shrub or treelet which is distributed from 
Pakistan, eastward to central of India, southern China, Myanmar, Laos, Vietnam, 
Philippines, Cambodia, Thailand, Malaysia, Singapore, Indonesia, and to Southern 
part of Africa (such as Mauritius, Madagascar and South Africa).  The C. serratum is 
found in grasslands, thickets, and secondary forest from sea-level up to 1700 m 
altitude. This plant can attain a height up to 4 m tall or sometimes climping. Its stems 
are relatively stout, mostly unbranched, nodes not annulate; leaves are elliptical to 
obovate, 7-22 cm x 3-8 cm, base acute to subcuneate, apex acute or short acuminate, 
margin serrate, glabrous on both surfaces, petiole 0.3-1.2 cm long; axillary cymes 3-
5 cm long (van Valkenburg & Bunypraphatsara, 2002). 
 
The classification of the Clerodendron serratum (Spreng.) according to (Burkill, 
1966) is as follows: 
Division Spermatophyta 
Sub division Magnoliophyta 
Class Magnoliopsida 
Sub class Asteridae 
Order Lamiales 
Family Verbenaceae 
Genus Clerodendron 
Species Clerodendron serratum (Spreng.). 
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The Malay name for C. serratum is timba tasek (the bucket of the lake), tẽnjal tasek 
(the plant with its foot on the lake), tambun tasek, taman tasek, sunga tasek, 
sẽnggugor (plant for miscarriage), lambin budak, and mata kẽsang (Burkill, 1966). 
Plate 1.1 shows the picture of Clerodendron serratum (Spreng.) leaves. 
 
                                                                                                               
 
Plate 1.1. Picture of Clerodendron serratum (Spreng.): (A) plant and (B) leaves. 
  
                                        A                                                             B            
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1.2.2. Biological Activity 
In Malaysia, the Malays use this plant more externally than internally. 
Poultice of C. serratum is used to treat ringworm, leprosy, headache, and persistent 
fever, foment for puru and embrocate for stiffness in the joints. The Malays give a 
decoction internally for colic. In India, decoction of the roots with ginger and 
coriander is taken for nausea and the tender leaves are eaten as a salad. Dutch 
authorities said that in the Dutch Indies, the roots were eaten to clear voice, the 
leaves were eaten during labour, an extract was given for an extended stomach and 
ripe and unripe fruits were chewed for coughs (Burkill, 1966). In addition to that, this 
plant is useful in treating pain (fever), inflammation, rheumatism, respiratory 
disorders and malarial infections (Narayanan et al., 1999). Moreover, this plant is 
consider as a central nervous system depressant, antihistaminic, hypotensive, 
bronchoconstrictor, antiallergic, antibiotic, antifertility and stomachic medicine as 
mentioned by Sharma et al., (2000).  
 
Narayanan et al., (1999) also reported that the ethanolic extract of C. 
serratum showed antinociceptive, anti-inflammatory and antipyretic effects in 
experimental animals. Vidya et al., (2007) reported that ethanolic extract of the C. 
serratum roots showed hepatoprotective activity. Asmawi et al., (1989) also reported 
that extract obtained from this plant, administered intravenously into anaesthetised 
rats lowered the blood pressure. In addition to that Nyman et al., (1998) also reported 
that root extracts of this plant inhibited angiotensin converting enzyme. Ethanolic 
extract of root of this plant were tested on two gram-positive and six gram-negative 
bacterial strains and found significantly inhibited the growth of Streptococcus 
pyogenes-A and Proteus mirabilis (Narayanan et al., 2004).  
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1.2.3. Phytochemistry 
 
A number of compounds have been isolated from C. serratum. The root bark 
contains triterpenoids, mainly sapogenins, oleanolic acid, queretaroic acid, and 
serratagenic acid (Rangaswami & Sarangan, 1969), whereas the leaves contain 
flavonoids, and phenolic acid (Sharma et al., 2009). Several other substances have 
been isolated and identified in C. serratum, including D-mannitol (Garg & Verma, 
1967; Banerjee et al., 1969), γ-sitosterol (Banerjee et al., 1969), plantarenaloside, 
euphroside, β-amyrin, apigenin, luteolin, and nepetin (van Valkenburg & 
Bunypraphatsara, 2002).  
 
In addition to that, triterpenes (bauer-9-en-3-one), steroids (spinasterol), 
steroid glucoside (spinasteryl-β-D-glucopyranoside), and disaccharide (sucrose) were 
isolated from twigs and stems of methanolic extract of C. serratum (Boonsri, 2004). 
Vidya et al., (2007) reported that another triterpene, ursolic acid, was isolated from 
the ethanolic extract of C. serratum roots. Ravikumar et al., (2008) isolated 
triterpines, serratin and lupeol from the essential oil of C. serratum. Flavonoids such 
as ferulic acid, scutellarein and baicalein were found in this plant (Sharma et al., 
2000). Hui et al., (2000) isolated monoterpene acid with monosaccharide derivatives 
named surratumin A, cis-cinnamic acid, trans-cinnamic acid, p-coumaric acid, 5, 7, 
8, 4-tetrahydroxy-6-methoxyflavone and 5, 6, 7-trihydroxy-4-methoxyflavone-7-0-
D-glucopyranoside. Wei et al., (2000) reported to find 7-β-coumaroyloxyugandoside, 
and 7-β-cinnamoyloxyugandoside. Banerjee, et al (1969) reported that the root bark 
of C. serratum does not contain any alkaloidal contents. Furthermore, Cannon et al., 
(1980) again reported that this plant does not contain any alkaloids. Some chemical 
structures of C. serratum constituents are presented in Figure 1.1. 
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Figure 1.1. (Continue.......) 
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Figure 1.1. Chemical structures of some of the C. serratum constituents 
 
 
 10 
 
1.1.4. Overall Objectives: 
1. To serially extract the leaves of C. serratum with different solvents using 
petroleum ether, chloroform, methanol, and water respectively by maceration 
method for further pharmacological evaluation. 
2. To fractionate the most potent pharmacologically active extract by solvent-
solvent partition method using separatory funnel. 
3. To perform phytochemical screening study of chemical groups present in 
most active extract/fraction by thin layer chromatography (TLC). 
4. To quantify the total phenolic and flavonoid contents of C. serratum leaves 
extracts and its fractions. 
5. To evaluate antioxidant activity of C. serratum leaves extracts and its 
fractions. 
6. To screen the antiangiogenic activity of C. serratum leaves extracts and its 
fractions. 
7. To determine the half maximal inhibitory concentration (IC50) value on blood 
vessels growth inhibition of most active extract/fraction of C. serratum 
leaves. 
8. To evaluate a possible vasorelaxant activity of C. serratum leaves extracts 
against noradrenaline (NA)-induced contraction of isolated rat aortic ring 
preparations. 
9. To perform the vasorelaxant activity study of different fractions of 
methanolic extract of C. serratum leaves against NA-induced contraction of 
isolated rat aortic ring preparations. 
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CHAPTER TWO 
PHYTOCHEMICAL SCREENING STUDY  
2.1. Introduction 
The first step of the extraction method is to release and solubilize the smaller 
secondary metabolites by a thorough solvent or aqueous extraction. This can be 
performed by a series of stepwise extractions, using different solvents of increasing 
polarity which should dissolve most natural products (Cannell, 1998). Hence, the 
extract is initially separated into various fractions containing compounds of relatively 
similar polarities. These fractions may be obvious, physically discrete divisions, such 
as the two phases of a liquid–liquid partition method. However, it is more difficult to 
design an isolation protocol for extract or fraction where the types of compounds 
present are totally unknown. In this situation, it is advisable to carry out qualitative 
tests for the presence of various types of compounds, for example, terpenoids, 
tannins, saponins, alkaloids, flavonoids, and so forth, as well as analytical thin-layer 
chromatography (TLC), followed by gravity column chromatography for isolation 
purpose of target compound (Sarker et al., 2005).  
 
2.2. Objectives 
1. To serially extract the leaves of C. serratum with different solvents (using 
petroleum ether, chloroform, methanol, and water respectively) by 
maceration method to test pharmacological evaluation. 
2. To fractionate the most potent pharmacologically active extract by solvent-
solvent partition method using separatory funnel. 
3. To perform phytochemical screening study of chemical groups present in 
most active extract/fraction by TLC. 
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2.3. Materials and Methods  
2.3.1. Instruments 
Fluorescence Analysis Cabinet, Model CX-20 
(Long wave UV 365nm, Short wave UV 254nm) 
Westbury, USA. 
Rotary evaporator  Büchi, Switzerland 
Water bath shaker model 903 Brotech, Malaysia. 
 
2.3.2. Chemicals 
Anisaldehyde reagent [C8H8O2] Sigma-Aldrich, Germany 
Chloroform Fisher Scientific, UK 
Dragendroff reagent Sigma-Aldrich, USA 
Glacial acetic acid R & M Chem, UK 
Lead acetate [Pb(CH3COO)2.3H2O] Bensoden, Laboratory Chemicals 
Methanol Fisher Scientific, UK 
Polyethylene glycol 4000 [PEG 4000] Merck, Germany 
Potassium hydroxide [KOH] Merck, Germany 
Petroleum ether Fisher Scientific, UK 
Silica gel 60 (70–230 mesh ASTM) Merck, Germany 
Sulphuric acid R & M Chem, UK 
 
2.3.3. Preparation of the Plant Materials 
The fresh green leaves of C. serratum leaves, locally known as ‘Timba tasek’, 
were collected between lowland of Maxwell Hill and Agriculture Department of 
District Larut, Taiping, Perak, Malaysia (from sea-level up to ±3.5 m altitude). The 
plant was collected in September 2006. The fresh green leaves of C. serratum, were 
washed under running tap water, separated from twigs, cleaned off adulterants, and 
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then dried in hot air oven at 40 0C for two days. The dried leaves were then grounded 
to fine powder using an electrically driven grinder. The plant was taxonomically 
identified as Clerodendron serratum, with the help of the late Abdulmajid Ahmed 
(May Allah have mercy on him) a staff of School of Pharmaceutical Sciences, 
Universiti Sains Malaysia. A voucher speciment of the plant (Reference number: 
10935) has been deposited at the Herbarium School of Biological Sciences, 
Universiti Sains Malaysia. 
 
2.3.4. Preparation of Extracts and Fractions of C. serratum Leaves 
2.3.4.1. Maceration Method  
The dried powdered leaves of C. serratum leaves (100g) were macerated 
sequentially with solvents of increasing polarity from petroleum ether (a defatting 
step), chloroform, methanol and water respectively in flasks (250 mL) in water bath 
shaker model 903 (Brotech, Malaysia) at 40 0C for 8 hours. The extraction procedure 
with each solvent was repeated three times. The combined filtrate obtained was 
filtered using Whatman filter paper and then the solvent was removed using a rotary 
evaporator (Büchi, Switzerland) under reduced pressure (Figure 2.1). The 
concentrated extracts were kept in a freezer at -70 0C for 48 hours and freezed dried 
for 48 hours. The dried extracts obtained were kept in tightly covered, labelled glass 
bottles and stored in desiccators. 
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Figure 2.1. Schematic diagram showing the extraction procedure of Clerodendron 
serratum (Spreng.) leaves. 
 
Dried Powdered Leaves of C. serratum (Spreng.) Leaves (100 g) 
 
Deffated with petroleum ether (3 x 250 mL) 
Extracted with chloroform (3 x 250 mL) 
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Extracted with water (3 x 250 mL) 
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Concentrated 
 
Blackish gum 
 
Concentrated 
 
Brownish gum 
 
Concentrated 
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2.3.4.2. Partition Method  
Since, methanolic extract of C. serratum leaves shown to be the most potent 
antioxidant, antiangiogenic and vasorelaxant effect amongst the four extracts. Then, 
the methanolic extract was subjected to a solvent-solvent partition process using 
solvents of increasing polarity from n-hexane, chloroform, ethyl acetate, n-butanol 
and water fraction respectively (Figure 2.2). 
 
The methanolic extract (200 g) was initially suspended in approximately 500 
mL of distilled water (37 0C) in a beaker. A glass rod was used to stir the mixture. 
The solvent obtained was then transferred into a separatory funnel. The solution was 
partitioned (equal volumes), with 3 x 250 mL of n-hexane using in a 1 litter volume 
separatory funnel. The resultant n-hexane layer was dried over using anhydrous 
sodium sulfate [Na2SO4]. The upper (n-hexane fraction) layer was poured out from 
the top of the separatory funnel to avoid contamination from the aqueous layer. The 
combined n-hexane filtrate fractions obtained was evaporated under reduced pressure 
using a rotary evaporator (Büchi, Switzerland) to yield a yellowish gum.  
 
The aqueous layer (water miscible organic portion) was subjected to partition 
process with 3 x 250 mL of chloroform. The bottom (chloroform fraction) layer was 
separated into a flask. The combined chloroform filtrate fractions obtained was 
evaporated under reduced pressure using a rotatory evaporator (Büchi, Switzerland) 
to yield a greenish gum.  
 
The aqueous layer was then partitioned with 3 x 250 mL of ethyl acetate. The 
upper (ethyl acetate fraction) layer was poured out from the top of the separatory 
 16 
 
funnel to avoid contamination from the aqueous layer. The resultant ethyl acetate 
layer was dried over using anhydrous sodium sulfate [Na2SO4]. The combined ethyl 
acetate fraction obtained was concentrated using a rotatory evaporator (Büchi, 
Switzerland) under reduced pressure and a yellowish gum was obtained.  
 
The aqueous layer was then extracted with 3 x 250 mL of n-butanol. The 
resultant n-butanol layer was dried over using anhydrous sodium sulfate [Na2SO4]. 
The upper (n-butanol fraction) layer was poured out from the top of the separatory 
funnel to minimize contamination from the aqueous layer. The combined n-butanol 
fraction obtained was concentrated on a rotatory evaporator (Büchi, Switzerland) 
under reduced pressure to yield a blackish gum. 
 
  The remaining aqueous solution (aqueous phase) obtained was 
concentrated using a rotatory evaporator (Büchi, Switzerland) under reduced 
pressure to yield a brownish gum of water fraction. The concentrated extracts 
obtained were kept in a freezer at -70 0C for 48 hours and freezed dried under 
reduced pressure at -40 0C for 48 hours to ensure complete dryness. The weights of 
the dried extracts obtained are shown in Table 2.2. These extracts were kept in 
tightly covered labelled glass bottles and stored in a desiccator. 
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Figure 2.2. Schematic diagram showing fractionation method of the methanolic 
extract of Clerodendron serratum (Spreng.) leaves. 
Partitioned with n-hexane (3 x 250 mL) 
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2.3.5. Sub-fractionations of n-Butanol Fraction of Methanolic Extract of C. 
serratum Leaves by Gravity Column Chromatography 
2.3.5.1. Preparation of Gravity Column Chromatography 
A sintered glass column chromatography measuring 105 cm long and 7 cm  
in diameter was attached to a ring stand and fastened in vertical position in a 
fumehood. A suspension of silica gel-60 (Cat No: 1.07734.1000, Merck, Germany) 
was prepared. The column was packed by filling about half-way with chloroform as 
eluting solvent system. Using a powder funnel, the translucent slurry was carefully 
transferred over a sintered glass column chromatography while swirling. A pasteur 
pipet was used to rinse, any silica that stucked on the sides of the column, with small 
amount of chloroform solvent. A recycled solvent was poured through the column 
several times until the column was firmly packed and silica gel becomes translucent. 
Then, the surface of silica gel was permanently kept covered with an eluting solvent 
system (Pavia et al., 1998; Fessenden et al., 2001).  
 
2.3.5.2. Pre-adsorption and Sub-fractionation of the Sample 
The n-butanol fraction (50g) was pre-adsorbed onto the adsorbent (1:2), silica 
gel-60 (70-230 mesh ASTM),  by dissolving the extract in methanol. Using a round 
bottom flask, the solvent was removed from the slurry on a rotary evaporator under 
reduced pressure. The sample mixture was scraped down the sides of the flask before 
the last solvent was removed from the flask. When the sample was dried in oven at 
40 0C, it was transferred to a mortar and grounded into a fine powder. The resultant 
dried fine powder of extract was placed onto the top of the column bed using a 
powder funnel. After loading the sample, a piece of small amount of non-absorbent 
cotton was added to the top of the column bed to prevent sample from being 
disturbed when fresh solvent is added. The successive eluates (100 mL) of sample 
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were collected into different pre-labeled conical flasks (Pavia et al., 1998; Fessenden 
et al., 2001). The eluting solvent system used as mobile phase in gravity column 
chromatography is shown in Table 2.1. 
 
Table 2.1. Ratio of Different Solvents Used as Mobile Phase in Gravity Column      
Chromatography. 
 
. 
Number 
Ratio of eluting solvent system  
Total volume (L) Methanol Chloroform                                  Water
1 5.0 95.0 0.0 2.0 
2 10.0 90.0 0.0 2.0 
3 15.0 85.0 0.0 2.0 
4 20.0 80.0 0.0 2.0 
5 25.0 75.0 0.0 2.0 
6 30.0 70.0 0.0 2.0 
8 35.0 65.0 0.0 2.0 
9 40.0 60.0 0.0 2.0 
10 45.0 55.0 0.0 2.0 
11 50.0 50.0 0.0 2.0 
12 65.0 35 10 2.0 
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2.3.6. Phytochemical Screening of Methanolic Extract and n-Butanol Fraction 
of C. serratum Leaves 
Preliminary  phytochemical screening was performed to detect the presence 
of alkoloids, flavonoids, triterpenoids, saponins, and tannins. A few milligrams of 
each sample were dissolved in methanol and 5-10 µL was spotted on thin layer 
chromatography (TLC) plates (5 x 10 cm). The TLC plates were developed using 
upper phase of n-butanol, acetic acid and water (5:1:4 v/v) in TLC chamber at room 
temperature. The developed chromatogram of test sample was sprayed with various 
specific spray reagents for detection of the respective classes of compounds.  
 
2.3.6.1. Detection of Alkaloids 
The developed TLC plate was sprayed with Dragendorff’s reagent [( Solution 
A: 0.85 g of basic bismuth nitrate was dissolved in 10 mL of glacial acetic acid  and 
40 mL distilled water), (Solution B: 8g of potasium iodide (KI) was dissolved in 30 
mL distilled water)]. The solution A was mixed with solution B (1:1) and used as 
stock solution. The Dragendorff’s reagent was prepared by mixing 5 mL of stock 
solution with 10 mL of glacial acetic acid and diluted with it to 50 mL of distilled 
water. Unstable orange-brown spots appear immediately under visible light indicates 
the presence of alkoloids (Wagner et al., 1984). 
 
2.3.6.2. Detection of Terpenoids 
The developed TLC plate was sprayed with anisaldehyde-sulphuric acid 
reagent and then heated for 5 min at 100 0C. The anisaldehyde-sulphuric acid reagent 
was prepared by mixing 0.5 mL of anisaldehyde  with 10 mL glacial acetic acid, 
followed by 85 mL methanol and 5 mL concentrated sulphuric acid. The appearance 
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of blue-violet fourescence to red violet spots under visible light and UV 365 nm 
indicates the presence of triterpenes (Wagner et al., 1984). 
 
2.3.6.3. Detection of Saponins 
Saponins, due to their surface-active properties, they may be recognized by 
regular shaking an aqueous solution of the sample and observing the production of 
foam in a test tube, which is stable approximately for 15 minutes (Wagner et al., 
1984; Silva et al., 1998; Tona et al., 1998). Forthing which persisted on warming 
indicates the presence of saponins (Owoyele et al., 2008).  
 
2.3.6.4. Detection of Flavonoids 
The developed TLC plate was sprayed with 10 mL of natural products-
polyethylene glycol reagent (NP/PEG) and then examined under UV 365 nm. The 
NP/PEG was prepared by mixing 10 mL of solution A (1% diphenylboric acid β-
ethylamino ester in methanol) followed by 8 mL of solution B (5% polyethylene 
glycol-4000 in  ethanol). The flourensence intensity is produced either immediately 
or 15 minutes after spraying.  The presence of dark yellow, blue and green 
flourescence under UV 365 nm indicates the presence of flavonoids (Wagner et al., 
1984). 
 
2.3.6.5. Detection of Tannins 
Almost an aqueous solution of extracts or fractions that contains hydrolysable 
tannins are precipitated by 1 mL (10% w/v) of lead acetate in addition of 1 mL (10% 
v/v) of acetic acid, while non-hydrolysable tannins (Condensed) are soluble in 
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addition of 1 mL (10% v/v) of acetic acid (El Sissi & El Sherbeiny, 1967; Wagner et 
al., 1984). 
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2.4. Results 
2.4.1. Extraction Yield of C. serratum Leaves  
The extraction yield obtained from maceration of C. serratum leaves using 
various solvents is summarized in Table 2.2. Amongst the four solvents, methanol 
produced the highest extraction yield. 
 
Table 2.2. The Extraction Yield Obtained from 100 g of Dried Powder Leaves of C. 
serratum. 
Number   Extract           Weight (g) % (w/w) 
1 Petroleum ether        4.50 4.5 
2 Chloroform 7.20 7.2 
3 Methanol 28.50 28.5 
4 Water                                               13.60 13.6 
 
 
2.4.2. Partition Yield of Methanolic Extract Fractions of C. serratum Leaves  
The methanolic extract of C. serratum leaves was fractionated using solvents 
of increasing polarity from n-hexane, chloroform, ethyl acetate, n-butanol and water 
respectively. The yield obtained from fractionation of methanolic extract of C. 
serratum leaves is shown in Table 2.3. 
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Table 2.3. The Fractionation Yield Obtained From the Methanolic Extract (200 g) of 
C. serratum Leaves Using Solvent-solvent Partition Method. 
Number    Fraction     Weight (g) % (w/w) 
1 n-hexane        1.10 0.5 
2 Chloroform 21.1 10.55 
3 Ethyl acetate 6.90 3.45 
4 n-butanol                                              78.9 39.45 
5 Water 83.7 41.85 
 
 
2.4.3. Column Chromatography 
The n-butanol fraction of methanolic extract of C. serratum was 
chromatographed and eluted with eluting solvent system mentioned in Table 2.1. The 
eluate in each flask was concentrated to about 50 mL using rotary evaporator. Then, 
an  aliquot of each fraction were spotted onto a thin layer chromatography (TLC) 
plate. TLC plates were developed using the upper phase of n-butanol, acetic acid and 
water (5:1:4 v/v) as mobile phase. Those eluates giving the same profiles were 
pooled together. The combination of eluates yielded ten sub-fractions which were not 
fully dried and labelled as (A) 1.20, (B) 1.70, (C) 1.14, (D) 3.43, (E) 0.70, (F) 8.00, 
(G) 15.50, (H) 1.50, (I) 11.23 and (J) 1.30 g  respectively. The sub-fraction I (12.23 
g) that showed as targeted compound by thin layer chromatography have been 
successfully isolated from n-butanol fraction of C. serratum leaves but need further 
purification steps.  
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2.4.4.  Phytochemical Screening of Methanolic Extract, n-Butanol Fraction and 
Sub-fraction of C. serratum Leaves 
2.4.4.1. Detection of the Presence of Alkaloids 
The developed chromatograms of the methanolic extract, n-butanol fraction 
and n-butanol sub-fraction of C. serratum leaves were sprayed with Dragendorff's 
reagent and examined under visible light. The result showed that there was no 
orange-brown zone observed in methanol extract, n-butanol fraction and n-butanol 
sub-fraction (i) of C. serratum leaves which indicated the absence of any alkaloids 
(Plate 2.1).  
 
2.4.4.2. Detection of the Presence of Flavonoids  
The developed chromatograms of the methanolic extract, n-butanol fraction 
and n-butanol sub-fraction (i), of C. serratum leaves was first examined under UV 
365nm and then was sprayed with natural product reagent (NP/PEG) in order to 
intensify the fluorescence quenching. The presence of blue coloured spots under UV 
365 nm before and after spraying indicated the presence of flavonoids (Plate 2.2).  
 
2.4.4.3. Detection of the Presence of Terpenoids  
The developed chromatograms of the methanolic extract, n-butanol fraction 
and n-butanol sub-fraction (i) of C. serratum leaves were sprayed with anisaldehyde-
sulphuric acid reagent. Then they were examined under visible light and UV 365 nm. 
After being sprayed with anisaldehyde-sulphuric acid reagent the appearance of blue 
and green coloured spots under UV 365 nm indicated the presence of terpenoids 
(Plate 2.3). 
  
